UPSHER-SMITH 0228 50 mg Pill - blue capsule/oblong, 18mm
Pill with imprint UPSHER-SMITH 0228 50 mg is Blue, Capsule/Oblong and has been identified as Morphine Sulfate Extended-Release 50 mg. It is supplied by Upsher-Smith Laboratories, Inc.
Morphine is used in the treatment of Chronic Pain; Neonatal Abstinence Syndrome; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Morphine 50 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for UPSHER-SMITH 0228 50 mg


Morphine Sulfate Extended-Release
- Imprint
- UPSHER-SMITH 0228 50 mg
- Strength
- 50 mg
- Color
- Blue
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Upsher-Smith Laboratories, Inc.
- National Drug Code (NDC)
- 00832-0228
- Inactive Ingredients
-
microcrystalline cellulose,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
polyethylene glycol 4000,
diethyl phthalate,
magnesium silicate,
titanium dioxide,
FD&C Blue No. 1,
FD&C Red No. 40
Note: Inactive ingredients may vary.
More about morphine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (366)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
- Morphine drug information
- Morphine injection
- Morphine (Epidural) (Advanced Reading)
- Morphine Extended-Release Capsules
- Morphine Immediate-Release Tablets and Capsules
Other brands
MS Contin, MorphaBond ER, Kadian, Astramorph PF, ... +10 more
Professional resources
- Morphine Sulfate monograph
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Oral Solution (FDA)
Other brands
MS Contin, MorphaBond ER, Kadian, Astramorph PF, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.